Preparation, standardization and in vitro safety testing of Mycobacterium nosodes (Emtact- polyvalent nosode)

Background: Most of the nosodes in the homeopathic pharmacopeia have been sourced from obscure pathological material over a century ago; of which no scientific documentation is available.

Method: A method for preparation and standardization of univalent and polyvalent Mycobacterium nosodes (labeled as Emtact), using different strains of Mycobacterium tuberculosis was developed. The committee comprising microbiologists, scientist, pharmacist, homeopaths and clinicians had reviewed and approved the method of preparation of nosode. Preparation of the nosode was based on the reference in the Homeopathy Pharmacopoeia of India (HPI), group N-IV. Strains of M. tuberculosis viz. Standard strain H37Rv, multi-drug resistant (MDR) M. tuberculosis, Mycobacterium bovis (BCG vaccine) and Mycobacterium avium were identified, procured and documented. Twenty billion viable cells for each strain were taken for Original Stock Nosode (OSN). The original stock was prepared by suspending the microbial cells into water for injection (WFI) (1 ml). As per the Indian Pharmacopoeia (IP) monograph, sterility testing was done for different potencies. Polymerase Chain Reaction (PCR) was performed for 30c potency for detection of any DNA material of the source organisms.

Result: A polyvalent (multi-strain) and univalent M. tuberculosis nosodes were prepared for research and clinical use. No growth of Mycobacterium was observed in any of the samples above 5c potency. The in-vitro testing for nosode (30c) was found to be free from any organism and DNA material.

Conclusion: Mycobacterium nosodes sourced from individual strain and polyvalent Emtact nosode in vitro testing results found to be satisfactory for its handling and utilization. The nosode seems to be safe and may be tested further in vivo to explore its therapeutic application.

Keywords

Nosode - Mycobacterium tuberculosis - Emtact - Standardization - Polyvalent - Potentization - Safety - PCR

• References

• 1 Chikramane P., Suresh A., Bellare J., Kane S. Extreme homeopathic dilutions retain starting materials: a nanoparticulate perspective. Homeopathy 99 (04) 2010; 231-242.
• 2 Shah R. Scientific method of preparing homoeopathic nosodes. Indian J Res Homoeopathy [Serial Online] 8 2014; 166-174 [cited 2014 Oct 21]. Available from: http://www.ijrh.org/text.asp?2014/8/3/166/141740.
• 3 Sarkar B.K. Up-to-date with nosodes. Reprint edn 1971. Roy Publishing House; Kolkata: 20.
• 4 Nosodes in homeopathy practice – an ECCH survey July 2008 accessed from website http://www.aeha-buendnis.de/webyep-system/programm/download.php?FILENAME=10-2-at-Dateianhang.pdf&ORG_FILENAME=Nosodes_in_homeopathy_practice_-_ECCH_survey_July_2008.pdf on date 06 Aug 2013.
• 5 Nosodes in homeopathy: significant and safe 2006. Position paper, ECHAMP. Accessed from website http://www.echamp.eu/fileadmin/user_upload/Positions/Nosodes_in_Homeopathy.pdf on date 06 Aug 2013.
• 6 Allen T.F. The Encyclopedia of Pure MateriaMedica. Vol 8 1988. B. Jain Publishers; New Delhi: 164.
• 7 Hering C. Reprint edn Guiding symptoms of our MateriaMedica. Vol 10 1989. B Jain Publishers; New Delhi: 350-356.
• 8 Allen H.C. MateriaMedica of the nosodes. Reprinted edn 1988. B Jain Publishers; New Delhi.:
• 9 Research updates-homeopathy. IPRH Feb 2013; 2(2): 10e23. ejournal, ISSN 2278 4500. Available online at: http://audesapere.in/ejournal/427/.
• 10 Gustavo B., Enrique V., Rolando F. et al. Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control. Homeopathy 99 2010; 156-166 10.1016/j.homp.2010.05.009 The Faculty of Homeopathy, Available online at: http://www.sciencedirect.com.
• 11 http://safe-medicine.blogspot.in/2010/11/homeopathy-and-dengue-fever.html.
• 12 http://www.spiritindia.com/2003/dengue-fever-dengue-fever-in-delhi-and-homeopathy-365/.
• 13 Shah R. The preparation and homeopathic pathogenetic trial. Homeopathy 102 (03) 2013; 207-214.
• 14 Shah R. HIV nosode: the homeopathic pathogenetic trial. Forsch Komplementärmedizin 22 (03) 2015; June 23 156-162 10.1159/000435845 Link: http://www.karger.com.
• 15 Homoeopathic pharmacopeia of India. 1st edn Vol 4 1983. Ministry of Health Government of India; New Delhi: 136-137.
• 16 www.haffkineinstitute.org.
• 17 Indian pharmacopeia. 4th edn; 2010. Annexure 10. New Delhi.